×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
Worldwide schedules comment Share
8222 views

Animateurs:

  • Dr Gwenaël Ferron, chirurgien oncologue Institut Universitaire du Cancer Toulouse
  • Coralie Marjollet, Imagyn

La Société Française de Chirurgie Oncologique s’associe à l’association IMAGYN pour un webinar ONCOSTREAM sur les Tumeurs Rares de l'Ovaire à destination des patientes et des professionnels de santé.

Quelques exemples des thèmes qui seront abordés lors de cette réunion interactive entre oncologues experts du groupe GINECO, spécialistes de soins de support et les patientes :

  • Qu'est-ce qu'une tumeur rare de l'ovaire ?
  • Pourquoi cela touche des femmes jeunes voire des adolescentes ?
  • Quels sont les traitements proposés et pourquoi ?
  • Comment prévenir et prendre en charge les séquelles de traitements, en particulier la fertilité, la ménopause, la sexualité ?
  • Comment accompagner au mieux les patientes et leurs familles? Place de l'association de patientes IMAGYN
  • Quel est le rôle du réseau de centres experts TMRO ?

Afin de pouvoir poser vos questions en direct aux intervenants un chat sera mis à votre disposition.

Shooting date : 2021-05-10
Last update : 2024-02-13
1 comment
Join the Discussion
  • Lauriane G. merci pour la presentation

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Tuesday, April 29th 2025 from 01pm to 01:45pm (GMT+2)
    Honolulu : Tuesday, April 29th 2025 from 01am to 01:45am (GMT+2)
    San Francisco : Tuesday, April 29th 2025 from 04am to 04:45am (GMT+2)
    New York : Tuesday, April 29th 2025 from 07am to 07:45am (GMT+2)
    Buenos Aires : Tuesday, April 29th 2025 from 08am to 08:45am (GMT+2)
    Reykjavik : Tuesday, April 29th 2025 from 11am to 11:45am (GMT+2)
    London / Dublin : Tuesday, April 29th 2025 from 12pm to 12:45pm (GMT+2)
    Paris / Berlin : Tuesday, April 29th 2025 from 01pm to 01:45pm (GMT+2)
    Istanbul : Tuesday, April 29th 2025 from 02pm to 02:45pm (GMT+2)
    Moscou / Dubaï : Tuesday, April 29th 2025 from 03pm to 03:45pm (GMT+2)
    Bangkok : Tuesday, April 29th 2025 from 06pm to 06:45pm (GMT+2)
    Shanghai : Tuesday, April 29th 2025 from 07pm to 07:45pm (GMT+2)
    Tokyo : Tuesday, April 29th 2025 from 08pm to 08:45pm (GMT+2)
    Sydney : Tuesday, April 29th 2025 from 10pm to 10:45pm (GMT+2)
    Wellington : Wednesday, April 30th 2025 from 12am to 12:45am (GMT+2)

    Comment prendre en charge un cancer de l'endomètre avancé ?

    Cancer de l’endomètre avancé pMMR NSMP (épisode 4)

    Share
    Thursday, May 22nd 2025 from 09am to 06:30pm (GMT+2)
    Honolulu : Wednesday, May 21st 2025 from 09pm to 06:30am (GMT+2)
    San Francisco : Thursday, May 22nd 2025 from 12am to 09:30am (GMT+2)
    New York : Thursday, May 22nd 2025 from 03am to 12:30pm (GMT+2)
    Buenos Aires : Thursday, May 22nd 2025 from 04am to 01:30pm (GMT+2)
    Reykjavik : Thursday, May 22nd 2025 from 07am to 04:30pm (GMT+2)
    London / Dublin : Thursday, May 22nd 2025 from 08am to 05:30pm (GMT+2)
    Paris / Berlin : Thursday, May 22nd 2025 from 09am to 06:30pm (GMT+2)
    Istanbul : Thursday, May 22nd 2025 from 10am to 07:30pm (GMT+2)
    Moscou / Dubaï : Thursday, May 22nd 2025 from 11am to 08:30pm (GMT+2)
    Bangkok : Thursday, May 22nd 2025 from 02pm to 11:30pm (GMT+2)
    Shanghai : Thursday, May 22nd 2025 from 03pm to 12:30am (GMT+2)
    Tokyo : Thursday, May 22nd 2025 from 04pm to 01:30am (GMT+2)
    Sydney : Thursday, May 22nd 2025 from 06pm to 03:30am (GMT+2)
    Wellington : Thursday, May 22nd 2025 from 08pm to 05:30am (GMT+2)

    16e congrès de la SFCO

    Rediffusion en direct

    Share
    Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, November 21st 2023 from 06am to 07:30am (GMT+1)
    San Francisco : Tuesday, November 21st 2023 from 08am to 09:30am (GMT+1)
    New York : Tuesday, November 21st 2023 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Tuesday, November 21st 2023 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Tuesday, November 21st 2023 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Tuesday, November 21st 2023 from 05pm to 06:30pm (GMT+1)
    Istanbul : Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, November 21st 2023 from 08pm to 09:30pm (GMT+1)
    Bangkok : Tuesday, November 21st 2023 from 11pm to 12:30am (GMT+1)
    Shanghai : Wednesday, November 22nd 2023 from 12am to 01:30am (GMT+1)
    Tokyo : Wednesday, November 22nd 2023 from 01am to 02:30am (GMT+1)
    Sydney : Wednesday, November 22nd 2023 from 02am to 03:30am (GMT+1)
    Wellington : Wednesday, November 22nd 2023 from 04am to 05:30am (GMT+1)

    Cancer de l'ovaire : comment évaluer aujourd'hui la recombinaison homologue ?

    Share
    Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
    Honolulu : Wednesday, January 31st 2024 from 06am to 07:30am (GMT+1)
    San Francisco : Wednesday, January 31st 2024 from 08am to 09:30am (GMT+1)
    New York : Wednesday, January 31st 2024 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Wednesday, January 31st 2024 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Wednesday, January 31st 2024 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Wednesday, January 31st 2024 from 05pm to 06:30pm (GMT+1)
    Istanbul : Wednesday, January 31st 2024 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Wednesday, January 31st 2024 from 08pm to 09:30pm (GMT+1)
    Bangkok : Wednesday, January 31st 2024 from 11pm to 12:30am (GMT+1)
    Shanghai : Thursday, February 1st 2024 from 12am to 01:30am (GMT+1)
    Tokyo : Thursday, February 1st 2024 from 01am to 02:30am (GMT+1)
    Sydney : Thursday, February 1st 2024 from 02am to 03:30am (GMT+1)
    Wellington : Thursday, February 1st 2024 from 04am to 05:30am (GMT+1)

    KELIM ou comment optimiser l’utilisation du CA 125 dans la prise en charge du cancer de l’ovaire...

    Share
    Scroll Up